Entera Bio Ltd. has appointed Geno J. Germano as Chairman of the Board, effective February 4, 2026. Germano succeeds Gerald Lieberman and brings extensive experience from previous leadership roles at Pfizer, Wyeth, and other biopharma companies.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entera Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-000355), on February 09, 2026, and is solely responsible for the information contained therein.